FTSE MIB
35.398,82 -11,31 (-0,03%) Dow Jones
40.003,59 +134,21 (+0,34%) Nasdaq
16.685,97 -12,35 (-0,07%) Nikkei 225
38.787,38 -132,88 (-0,34%) Petrolio
80,00 +0,77 (+0,97%) Bitcoin EUR
61.572,33 +1.466,35 (+2,44%)
ATOS May 2024 2.000 put
| Chiusura precedente | 0,3400 |
| Aperto | 0,3000 |
| Denaro | 0,2000 |
| Lettera | 1,2000 |
| Prezzo d'esercizio | 2,00 |
| Scadenza | 2024-05-17 |
| Min-Max giorno | 0,2000 - 0,3500 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 116 |
GlobeNewswireAtossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023
SEATTLE, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a focus on breast cancer, today announces that the Company will take part in the upcoming Cantor Fitzgerald Global Healthcare Conference 2023. Details of the company's participation are as follows: Cantor Fitzgerald Global Healthcare Conference 2023Format: Fireside Chat with
- GlobeNewswire
Atossa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Achieved significant enrollment milestones in three ongoing Phase 2 clinical trialsBroadened patent protection for proprietary (Z)-endoxifenStrengthened management team with appointment of Greg Weaver as Chief Financial OfficerEnded second quarter 2023 with $99.4 million of cash and cash equivalents SEATTLE, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unme
- GlobeNewswire
Atossa Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 14, 2023
SEATTLE, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines to address significant unmet needs in cancer, today announced that it will provide a business update and report financial results for the second quarter 2023 on Monday, August 14, 2023. Company management will host a conference call to review the results at 9:00 a.m. ET / 6:00 a.m. PT on August 14, 2023. Second Quarter 2023 Conference Cal
